188 related articles for article (PubMed ID: 16804637)
21. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.
Guan H; Liu Y; Daily A; Police S; Kim MH; Oddo S; LaFerla FM; Pauly JR; Murphy MP; Hersh LB
J Neurosci Res; 2009 May; 87(6):1462-73. PubMed ID: 19021293
[TBL] [Abstract][Full Text] [Related]
22. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
23. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice.
Levites Y; Jansen K; Smithson LA; Dakin R; Holloway VM; Das P; Golde TE
J Neurosci; 2006 Nov; 26(46):11923-8. PubMed ID: 17108166
[TBL] [Abstract][Full Text] [Related]
24. The degradation of Abeta(25-35) by the serine protease plasmin is inhibited by aluminium.
Korchazhkina OV; Ashcroft AE; Kiss T; Exley C
J Alzheimers Dis; 2002 Oct; 4(5):357-67. PubMed ID: 12446968
[TBL] [Abstract][Full Text] [Related]
25. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
26. Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease.
Baig AM
ACS Chem Neurosci; 2019 Jan; 10(1):21-24. PubMed ID: 30160095
[TBL] [Abstract][Full Text] [Related]
27. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
[TBL] [Abstract][Full Text] [Related]
28. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease.
Bastianetto S; Krantic S; Quirion R
Mini Rev Med Chem; 2008 May; 8(5):429-35. PubMed ID: 18473932
[TBL] [Abstract][Full Text] [Related]
29. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
30.
Jean L; Brimijoin S; Vaux DJ
J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
[TBL] [Abstract][Full Text] [Related]
31. Amyloid binding ligands as Alzheimer's disease therapies.
Lee VM
Neurobiol Aging; 2002; 23(6):1039-42. PubMed ID: 12470800
[TBL] [Abstract][Full Text] [Related]
32. Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
Li B; Yu D; Xu Z
Brain Res; 2014 Jan; 1545():35-44. PubMed ID: 24333930
[TBL] [Abstract][Full Text] [Related]
33. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
[TBL] [Abstract][Full Text] [Related]
34. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
Dunys J; Valverde A; Checler F
J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
[TBL] [Abstract][Full Text] [Related]
35. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.
Petrushina I; Ghochikyan A; Mktrichyan M; Mamikonyan G; Movsesyan N; Davtyan H; Patel A; Head E; Cribbs DH; Agadjanyan MG
J Neurosci; 2007 Nov; 27(46):12721-31. PubMed ID: 18003852
[TBL] [Abstract][Full Text] [Related]
37. Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides.
Evin G; Weidemann A
Peptides; 2002 Jul; 23(7):1285-97. PubMed ID: 12128085
[TBL] [Abstract][Full Text] [Related]
38. Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.
Zhang YW; Xu H
Curr Mol Med; 2007 Nov; 7(7):687-96. PubMed ID: 18045146
[TBL] [Abstract][Full Text] [Related]
39. Differential regulation of amyloid precursor protein sorting with pathological mutations results in a distinct effect on amyloid-β production.
Lin YC; Wang JY; Wang KC; Liao JY; Cheng IH
J Neurochem; 2014 Nov; 131(4):407-12. PubMed ID: 25053581
[TBL] [Abstract][Full Text] [Related]
40. A Curcumin Analog Reduces Levels of the Alzheimer's Disease-Associated Amyloid-β Protein by Modulating AβPP Processing and Autophagy.
Wan Y; Liang Y; Liang F; Shen N; Shinozuka K; Yu JT; Ran C; Quan Q; Tanzi RE; Zhang C
J Alzheimers Dis; 2019; 72(3):761-771. PubMed ID: 31640096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
